Study Stopped
difficulty of inclusion
Respiratory Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease
REHABDO
Respiratory Rehabilitation at Home vs in the Center for Patients With Chronic Obstructive Pulmonary Disease: Efficacy, Preferences and Costs
3 other identifiers
interventional
188
1 country
7
Brief Summary
The aim of this clinical trial is to establish the non-inferiority of home-based respiratory rehabilitation compared to respiratory rehabilitation in center in terms of exercise tolerance as evaluated by the 6 minutes Stepper test.. This trial will also 1°) evaluate the Medico-economic aspects of the home-based Respiratory rehabilitation versus respiratory Rehabilitation in center; 2°) analyse the patient preferences between home-based respiratory rehabilitation and respiratory rehabilitation in center and 3°) Compare home-based respiratory rehabilitation vs respiratory rehabilitation in center in terms of dyspnea, quality of life, anxiety and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease
Started Oct 2018
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2018
CompletedFirst Posted
Study publicly available on registry
March 5, 2018
CompletedStudy Start
First participant enrolled
October 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2022
CompletedDecember 11, 2025
December 1, 2025
3.9 years
February 16, 2018
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline the 6 minutes Stepper test at 2 months
The 6 minutes stepper test (ST6), performed on a Stepper allows to analyze the number of strokes (or steps) performed in 6 minutes
At 2 months
Secondary Outcomes (7)
Change from baseline the 6 minutes Stepper test at 6 and 12 months
at 6 months, at12 months
Percentage of patients expressing a preference marked for home-based respiratory rehabilitation or respiratory rehabilitation in center
Baseline
Cost of interventions: respiratory rehabilitation in center or at home
At 12 months
Change from Baseline COPD Assessment Test (CAT) at 2,6,12 months
baseline, after RR (2 months); 6 months and12 months
Change from Baseline Modified Medical Research Council (MMRC) Dyspnea Scale at 2,6,12 months
baseline, after RR (2 months); 6 months and12 months
- +2 more secondary outcomes
Study Arms (2)
home group
ACTIVE COMPARATORcenter group
ACTIVE COMPARATORInterventions
Home care is individual (often with the spouse or the carer), during 1h30, one visit per week for 8 weeks, after completion of the educational diagnosis, under direct supervision of a member of the team, with continued physical activities in autonomy the others days of the week, according to a personalized action plan. No visit is scheduled in the pulmonologist, the general practitioner or in the rehabilitation center. The team includes pulmonologist, nurses, dietician, socio-medical beautician and a administrative assistant.
In an outpatient setting, the course is performed in groups of 6 to 8 patients, during sessions from 3 to 7 am, under the direction of health professionals, 3 to 5 times a week, for 4 to 6 weeks, for a total of 20 to 24 sessions. Internally, patients come to "complete" hospitalization for 4 weeks. This duration can be modulated according to the evolution of the patients. Supervision is carried out by the entire team including pulmonologists, nurses, physiotherapists, psychologists, activity professors adapted physicists, dietician
Eligibility Criteria
You may not qualify if:
- According to the recommendations, HAS, SPLF, ERS / ATS will not be included any patient having :
- co-morbidities including unstabilized cardiovascular disease,
- significant cognitive disorders: patients with a history of pathologies neurodegenerative with loss of mental faculties (example: Alzheimer)
- psychiatric disorders: patients with impaired judgment and perception
- neurological or orthopedic disorders that do not allow the realization of physical activities
- Also, will not be included, the patient (s):
- waiting for lung transplantation,
- pregnant or nursing,
- in an emergency situation
- unable to receive enlightened information,
- unable to participate in the entire study,
- not covered by the social security scheme,
- refusing to sign the consent,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Lillelead
- Ministry of Health, Francecollaborator
Study Sites (7)
Centre hospitalier de béthune
Béthune, France
CH de Béthune
Béthune, France
Hôpital Calmette, CHU
Lille, France
CH de Loos
Loos, France
CH Victor Provot, Roubaix
Roubaix, France
CH de Tourcoing
Tourcoing, France
CH de Wattrelos
Wattrelos, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Le Rouzic, MD,PhD
University Hospital, Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2018
First Posted
March 5, 2018
Study Start
October 24, 2018
Primary Completion
September 16, 2022
Study Completion
September 16, 2022
Last Updated
December 11, 2025
Record last verified: 2025-12